SPNE - シ―スパイン・ホ―ルディングス (SeaSpine Holdings Corporation)

SPNEのニュース

   Financial Analysis: SeaSpine (NASDAQ:SPNE) vs. Femasys (NASDAQ:FEMY)  2021/11/30 06:22:41 ETF Daily News
SeaSpine (NASDAQ:SPNE) and Femasys (NASDAQ:FEMY) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Profitability This table compares SeaSpine and Femasys net margins, return on equity and return on assets. Net [] The post Financial Analysis: SeaSpine (NASDAQ:SPNE) vs. Femasys (NASDAQ:FEMY) appeared first on ETF Daily News .
   SeaSpine announces full commercial launch of Admiral ACP System  2021/11/23 21:29:42 Seeking Alpha
   SeaSpine Announces Full Commercial Launch of the Admiral ACP System  2021/11/23 21:05:00 Intrado Digital Media
CARLSBAD, Calif., Nov. 23, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of its Admiral ACP System. Admiral ACP represents the next generation of anterior cervical plating and was designed to strike the optimal balance between strength, profile and construct rigidity. Differentiated plate features, combined with step-eliminating innovative instrumentation, work seamlessly in the surgeons hands to create a more efficient and consistent anterior cervical discectomy and fusion (ACDF) experience.
   Spinal Posterior Fixation System Market 2021 Size with Top Countries Industry Chain Structure, Competitive Landscape, Future Trends, New Projects and Forecasts up to 2027 - SeaSpine, NuVasive, Silony Medical, B. Braun  2021/11/22 09:18:27 OpenPR
The Spinal Posterior Fixation System Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts
   Analyzing SeaSpine (NASDAQ:SPNE) & Utah Medical Products (NASDAQ:UTMD)  2021/11/18 15:44:42 Dakota Financial News
SeaSpine (NASDAQ:SPNE) and Utah Medical Products (NASDAQ:UTMD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, institutional ownership, profitability and earnings. Risk & Volatility SeaSpine has a beta of 1.12, meaning that its share price is []
   Spinal Implants Market revenue to cross USD 11.7 Bn by 2027: Global Market Insights Inc.  2021/11/08 11:30:00 Intrado Digital Media
Major spinal implants market players include Medtronic plc, Johnson & Johnson, Zimmer Biomet, Stryker, Nuvasive, Globus Medical Inc., Alphatec Holdings, Inc., Surgalign Holdings, B. Braun Melsungen AG and SeaSpine Holdings Corporation. Major spinal implants market players include Medtronic plc, Johnson & Johnson, Zimmer Biomet, Stryker, Nuvasive, Globus Medical Inc., Alphatec Holdings, Inc., Surgalign Holdings, B. Braun Melsungen AG and SeaSpine Holdings Corporation.
   SeaSpine (NASDAQ:SPNE) Downgraded by Zacks Investment Research to Sell  2021/11/06 10:52:45 Dakota Financial News
Zacks Investment Research cut shares of SeaSpine (NASDAQ:SPNE) from a hold rating to a sell rating in a report published on Wednesday morning, Zacks.com reports. According to Zacks, SeaSpine Holdings Corporation is a medical technology company which focused on the design, development and commercialization of surgical solutions for the treatment of spinal disorders. The company []
   SeaSpine (NASDAQ:SPNE) Lowered to Sell at Zacks Investment Research  2021/11/04 10:22:44 Dakota Financial News
Zacks Investment Research cut shares of SeaSpine (NASDAQ:SPNE) from a hold rating to a sell rating in a research note published on Wednesday, Zacks.com reports. According to Zacks, SeaSpine Holdings Corporation is a medical technology company which focused on the design, development and commercialization of surgical solutions for the treatment of spinal disorders. The company []
   Piper Sandler Weighs in on SeaSpine Holdings Co.s Q1 2023 Earnings (NASDAQ:SPNE)  2021/11/01 08:46:41 Dakota Financial News
SeaSpine Holdings Co. (NASDAQ:SPNE) Equities researchers at Piper Sandler issued their Q1 2023 earnings estimates for SeaSpine in a research report issued on Thursday, October 28th. Piper Sandler analyst M. Obrien expects that the medical equipment provider will post earnings of ($0.28) per share for the quarter. Piper Sandler also issued estimates for SeaSpines []
   SeaSpine EPS misses by $0.18, beats on revenue  2021/10/28 20:50:22 Seeking Alpha
   SeaSpine continues to ride wave following 510k module clearance; shares up ~10%  2021/07/08 18:13:55 Seeking Alpha
   SeaSpine Lauded by Analysts After Spine Module Cleared by FDA  2021/07/08 16:57:38 The Street
The Food and Drug Administrations cleared SeaSpine''s 7D Percutaneous Spine Module for spinal surgery. The company''s shares are higher.
   SeaSpine Stock Is Trading Higher On FDA Approval For 7D Surgical Spine Module  2021/07/08 10:44:09 Benzinga
The FDA has given 510(k) clearance to SeaSpine Holdings Corporation''s (NASDAQ: SPNE ) 7D Percutaneous Spine Module for minimally invasive surgery. This news follows SeaSpine''s recent acquisition of 7D Surgical, a Toronto-based company … Full story available on Benzinga.com
   SeaSpine gets FDA 510k clearance for 7D surgical percutaneous spine module  2021/07/07 20:17:58 Seeking Alpha
   SeaSpine Announces FDA 510(k) Clearance of 7D Surgical Percutaneous Spine Module for Minimally Invasive Surgery  2021/07/07 20:05:00 Intrado Digital Media
CARLSBAD, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the FDA 510(k) clearance of its 7D Percutaneous Spine Module for minimally invasive surgery. This represents a new application and increased functionality for its 7D Flash™ Navigation System. This news follows SeaSpine’s recent acquisition of 7D Surgical, a Toronto-based company that develops advanced optical technologies and machine vision-based registration algorithms for surgical navigation to improve patient care. The Company is preparing a limited release of the Percutaneous Spine Module in the third quarter.

calendar